ImmuCell Corporation
ICCC | NASDAQ
$10.26
-$0.06 (-0.58%)
At close: Oct 30, 2026, 4:00 PM ET
$10.26
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
-0.58%
(1D)No price chart data available for 1D timeframe.
Rating
52
+1.0 ptsFundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #239/1028 (Top 23%)
Key Statistics
Market Data
Market Cap $93.18M
1D Range
9.98 10.60
52W Range
4.56 11.72
Valuation (TTM)
PE 121.28
PB 2.97
EV/EBITDA 27.37
Valuation (NTM)
Forward PE N/A
Forward PEG -0.31
Price Target $0.00
Cash Flow
FCF Yield 4.5%
SBC Adj. FCF Yield 3.9%
SBC Impact -13.2%
Margins
Gross Margin 40.3%
Operating Margin 12.6%
FCF Margin 13.7%
Growth (CAGR)
Revenue 3Y | 5Y 25.1% |
13.7%
Dil EPS 3Y | 5Y 361.0% |
53.4%
FCF 3Y | 5Y 151.7% |
1.2%
Returns
ROA 1.7%
ROE 2.7%
ROIC 8.1%
Financial Health
Net Cash
$557.32K
Current Ratio 4.75
Interest Coverage 8.93
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and b...
Sector Healthcare
Industry Biotechnology
Employees 73
IPO Date May 5, 1987
Website immucell.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove ICCC